Human IgG antibody Laboratories manufactures the sars-cov2 envelope proteine mybiosource reagents distributed by Genprice. The Sars-Cov2 Envelope Proteine Mybiosource reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Mybiosource. Other Sars-Cov2 products are available in stock. Specificity: Sars-Cov2 Category: Envelope Group: Proteine Mybiosource
SARS-Cov2-NP3-Antibody |
EnoGene |
100 μl |
EUR 276.5 |
Description: N/A |
SARS-Cov2-NP2-Antibody |
EnoGene |
N/A |
EUR 276.5 |
Description: N/A |
SARS-Cov2-NP2-Antibody |
EnoGene |
N/A |
EUR 276.5 |
Description: N/A |
SARS-Cov2-NP1-Antibody |
EnoGene |
N/A |
EUR 276.5 |
Description: N/A |
SARS-Cov2-NP1-Antibody |
EnoGene |
N/A |
EUR 276.5 |
Description: N/A |
SARS-CoV2-N-Antibody |
EnoGene |
N/A |
EUR 276.5 |
Description: N/A |
SARS-CoV2-N-Antibody |
EnoGene |
N/A |
EUR 276.5 |
Description: N/A |
Proteine Mybiosource information
SARS Envelope, His |
sars-004 |
ProSpec Tany |
50µg |
EUR 165 |
Description: Recombinant SARS Associated Coronavirus Envelope, His Tag |
Active Recombinant SARS-CoV-2 Envelope Protein |
RP01263LQ |
Abclonal |
1mg |
EUR 65 |
|
Recombinant Coronavirus Envelope Protein (SARS-CoV) |
P1534-10 |
Biovision |
10 µg |
EUR 187.2 |
Recombinant Coronavirus Envelope Protein (SARS-CoV) |
P1534-50 |
Biovision |
50 µg |
EUR 661.2 |
SARS Envelope Peptide |
3531P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) SARS Envelope peptide |
SARS Envelope Peptide |
3533P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) SARS Envelope peptide |
SARS Envelope Antibody |
24321-100ul |
SAB |
100ul |
EUR 468 |
SARS Envelope Antibody |
24322-100ul |
SAB |
100ul |
EUR 468 |
SARS Envelope Antibody |
24321 |
SAB |
100ul |
EUR 479 |
SARS Envelope Antibody |
24322 |
SAB |
100ul |
EUR 479 |
GENLISA Human SARS-CoV-2 (Covid-19) Envelope Protein Antigen Quantitative TITRATION ELISA |
KBVH015-30 |
Krishgen |
1 x 96 wells |
EUR 825 |
SARS Coronavirus Envelope Recombinant Protein |
39-104 |
ProSci |
0.05 mg |
EUR 556.8 |
Description: SARS Associated Coronavirus Envelope is a small membrane protein that takes major part in the life cycle of the virus. This protein is needed for the assembly, budding, creation of the envelope and pathogenesis. This protein contains 3 outer structural proteins, the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to assure viral entry thetarget cells. Accordingly, S-protein has a major part in virus infection cycle and is the mainly target of neutralizing antibodies. |
SARS Coronavirus Envelope Recombinant Protein |
39-118 |
ProSci |
0.1 mg |
EUR 556.8 |
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies. |
SARS Coronavirus Envelope Protein (Matrix) (E.coli) 100ug |
BSV-COV-PR-50 |
BioServUK |
100 ug |
Ask for price |
Description: SARS Coronavirus Envelope Protein (Matrix) (E.coli) 100ug |
SARS Coronavirus Envelope Protein (Matrix) (E.coli) 500ug |
BSV-COV-PR-51 |
BioServUK |
500 ug |
Ask for price |
Description: SARS Coronavirus Envelope Protein (Matrix) (E.coli) 500ug |
SARS-CoV-2 (COVID-19) Envelope Recombinant Protein N-terminal His Tag and Avi Tag |
ICOV2ETRNTHISAVI100UG |
Innovative research |
each |
EUR 867 |
|
Description: SARS-CoV-2 (COVID-19) Envelope Recombinant Protein N-terminal His Tag and Avi Tag |
SARS-CoV Envelope Antibody |
3533-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication. |